Capmatinib is meant to treat advanced non-small cell lung cancer with a specific type of mutation. It’s a special kind of inhibitor that targets the MET kinase to help stop tumor growth. You can get this drug in two tablet strengths, 150 mg and 200 mg.
The usual dose is 400 mg, taken two times a day, and it doesn’t matter if you take it with or without food. Each pack comes with a bottle that holds 60 tablets.
